Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 29, 2019	Dec. 30, 2018	Dec. 31, 2017
Operating activities
Net income before attribution to noncontrolling interests	$ 5,657	$ 4,073	$ 106,525
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for uncollectible accounts and notes receivable	3,139	6,849	29
Depreciation and amortization	47,281	46,403	43,668
Deferred income taxes	(3,764)	1,620	498
Preferred stock option mark-to-market adjustment	5,914
Stock-based compensation expense	15,303	9,936	10,413
(Gain) loss on refranchising	(4,739)	289
Impairment loss			1,674
Other	3,203	5,677	3,375
Changes in operating assets and liabilities:
Accounts receivable	(5,329)	2,157	(7,358)
Income tax receivable	12,122	(12,157)	(1,531)
Inventories	(326)	3,093	(5,485)
Prepaid expenses	792	(1,039)	(4,414)
Other current assets	(277)	4,834	(1,158)
Other assets and liabilities	(6,354)	1,464	(742)
Accounts payable	2,035	(400)	(8,743)
Income and other taxes payable	1,009	(3,971)	1,897
Accrued expenses and other current liabilities	(11,331)	21,753	(3,012)
Deferred revenue	(2,586)	1,873	(661)
Net cash provided by operating activities	61,749	92,454	134,975
Investing activities
Purchases of property and equipment	(37,711)	(42,028)	(52,593)
Loans issued	(15,864)	(10,463)	(8,103)
Repayments of loans issued	5,616	5,805	4,185
Acquisitions, net of cash acquired			(21)
Proceeds from divestitures of restaurants	13,495	7,707
Other	1,889	180	34
Net cash used in investing activities	(32,575)	(38,799)	(56,498)
Financing activities
Proceeds from issuance of preferred stock	252,530
Issuance costs associated with preferred stock	(7,527)
Proceeds from issuance of term loan			400,000
Repayments of term loan	(15,000)	(20,000)	(5,000)
Net (repayments) proceeds of revolving credit facility	(240,026)	163,585	(225,575)
Debt issuance costs		(1,913)	(3,181)
Dividends paid to common stockholders	(28,552)	(28,985)	(30,720)
Dividends paid to preferred stockholders	(10,020)
Tax payments for equity award issuances	(1,433)	(1,521)	(2,428)
Proceeds from exercise of stock options	16,010	2,699	6,260
Acquisition of Company common stock		(158,049)	(209,586)
Contributions from noncontrolling interest holders	840		2,956
Distributions to noncontrolling interest holders	(870)	(4,269)	(5,449)
Other	(526)	356	663
Net cash used in financing activities	(34,574)	(48,097)	(72,060)
Effect of exchange rate changes on cash and cash equivalents	53	(191)	365
Change in cash and cash equivalents	(5,347)	5,367	6,782
Cash and cash equivalents at beginning of period	33,258	27,891
Cash and cash equivalents at beginning of period		22,345	15,563
Cash and cash equivalents at end of period	$ 27,911	$ 33,258	27,891
Cash and cash equivalents at end of period			$ 22,345